Vanguard Fiduciary Trust
EDIT icon

Vanguard Fiduciary Trust’s Editas Medicine EDIT Stock Holding History

Vanguard Fiduciary Trust’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.41M Buy
742,950
+128,914
+21% +$377K ﹤0.01% 2567
2026
Q1 		$1.52M Buy
+614,036
New +$1.3M ﹤0.01% 2715

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Vanguard Fiduciary Trust's EDIT Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Editas Medicine (EDIT) stake by 21% in Q2 2026, buying an estimated $377K and bringing the position to 742,950 shares worth $2.41M. The position accounts for ﹤0.01% of the portfolio, ranked #2567.

Vanguard Fiduciary Trust first reported a position in EDIT in Q1 2026 and has held it in 2 quarters since. 212 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Vanguard Fiduciary Trust held 742,950 shares of Editas Medicine worth $2.41M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 128,914 Editas Medicine shares in Q2 2026, an estimated $377K.
  • Editas Medicine made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2567 holding.
  • Vanguard Fiduciary Trust first reported a position in Editas Medicine in Q1 2026 and has held it in 2 quarters since.
  • 212 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.